Showing results (61-70 of 92) with videos related to

Sort By:
Pageof 10
International Journal of Hematology|June 19, 2014
Treatment outcomes of adolescent acute lymphoblastic leukemia treated on Tokyo Children's Cancer Study Group (TCCSG) clinical trialsMotohiro Kato, Atsushi Manabe, Katsuyoshi Koh, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 2007
Prospective study of a pirarubicin, intermediate-dose cytarabine, and etoposide regimen in children with Down syndrome and acute myeloid leukemia: the Japanese Childhood AML Cooperative Study GroupKazuko Kudo, Seiji Kojima, Ken Tabuchi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 22, 2009
Risk-stratified therapy and the intensive use of cytarabine improves the outcome in childhood acute myeloid leukemia: the AML99 trial from the Japanese Childhood AML Cooperative Study GroupIchiro Tsukimoto, Akio Tawa, Keizo Horibe, et al.
British Journal of Haematology|December 2, 2011
Clinical significance of early T-cell precursor acute lymphoblastic leukaemia: results of the Tokyo Children's Cancer Study Group Study L99-15Takeshi Inukai, Nobutaka Kiyokawa, Dario Campana, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|December 18, 2007
[The unification of hematopoietic stem cell transplantation registry in Japan and establishment of the TRUMP system]Yoshiko Atsuta, Ritsuro Suzuki, Ayami Yoshimi, et al.
International Journal of Hematology|November 9, 2007
Unification of hematopoietic stem cell transplantation registries in Japan and establishment of the TRUMP SystemYoshiko Atsuta, Ritsuro Suzuki, Ayami Yoshimi, et al.
Pageof 10